Global Trends and Research Hotspots in Long COVID: A Bibliometric Analysis

Overview

Journal Int J Environ Res Public Health

Publisher MDPI

Specialties Environmental Health
Public Health

Date 2022 Mar 25

PMID 35329428

Authors

Hongxia Jin

Lu Lu

Haojun Fan

Affiliations

Soon will be listed here.

Abstract

Long COVID is a condition distinguished by long-term sequelae that occur or persist after the convalescence period of COVID-19. During the COVID-19 pandemic, more and more people who tested positive for SARS-CoV-2 experienced long COVID, which attracted the attention of researchers. This study aims to assess the pattern of long COVID research literature, analyze the research topics, and provide insights on long COVID. In this study, we extracted 784 publications from Scopus in the field of long COVID. According to bibliometric analysis, it is found that: developed countries in Europe and America were in leading positions in terms of paper productivity and citations. The and the were leading journals in the perspective of publications count, and had the highest number of citations. Author Greenhalgh T has the highest number of papers and citations. The main research topics were: pathophysiology, symptoms, treatment, and epidemiology. The causes of long COVID may be related to organ injury, inflammation, maladaptation of the angiotensin-converting enzyme 2 (ACE2) pathway, and mental factors. The symptoms are varied, including physical and psychological symptoms. Treatment options vary from person to person. Most patients developed at least one long-term symptom. Finally, we presented some possible research opportunities.

Citing Articles

Long COVID Research, 2020-2024: A PubMed-Based Bibliometric Analysis.

Honorato-Cia C, Cacho-Asenjo E, Martinez-Simon A, Aquerreta I, Nunez-Cordoba J Healthcare (Basel). 2025; 13(3).

PMID: 39942487 PMC: 11816931. DOI: 10.3390/healthcare13030298.

A critical analysis of UK media characterisations of Long Covid in children and young people.

Connor C, Kranert M, Mckelvie S, Clutterbuck D, McFarland S, Alwan N PLOS Glob Public Health. 2024; 4(11):e0003126.

PMID: 39602373 PMC: 11602070. DOI: 10.1371/journal.pgph.0003126.

Artificial intelligence empowering rare diseases: a bibliometric perspective over the last two decades.

Ou P, Wen R, Shi L, Wang J, Liu C Orphanet J Rare Dis. 2024; 19(1):345.

PMID: 39272071 PMC: 11401438. DOI: 10.1186/s13023-024-03352-1.

Prevalence, predictors, and patient-reported outcomes of long COVID in hospitalized and non-hospitalized patients from the city of São Paulo, Brazil.

Malheiro D, Bernardez-Pereira S, Parreira K, Pagliuso J, de Paula Gomes E, de Mesquita Escobosa D Front Public Health. 2024; 11:1302669.

PMID: 38317683 PMC: 10839020. DOI: 10.3389/fpubh.2023.1302669.

Visual analysis of hotspots and trends in long COVID research based on bibliometric.

Lai Z, Pu T, Li J, Bai F, Wu L, Tang Y Heliyon. 2024; 10(2):e24053.

PMID: 38293444 PMC: 10827472. DOI: 10.1016/j.heliyon.2024.e24053.

References

Bai F, Tomasoni D, Falcinella C, Barbanotti D, Castoldi R, Mule G . Female gender is associated with long COVID syndrome: a prospective cohort study. Clin Microbiol Infect. 2021; 28(4):611.e9-611.e16. PMC: 8575536. DOI: 10.1016/j.cmi.2021.11.002. View

Ward H, Flower B, Garcia P, Ong S, Altmann D, Delaney B . Global surveillance, research, and collaboration needed to improve understanding and management of long COVID. Lancet. 2021; 398(10316):2057-2059. PMC: 8580495. DOI: 10.1016/S0140-6736(21)02444-2. View

Renaud-Charest O, Lui L, Eskander S, Ceban F, Ho R, Di Vincenzo J . Onset and frequency of depression in post-COVID-19 syndrome: A systematic review. J Psychiatr Res. 2021; 144:129-137. PMC: 8482840. DOI: 10.1016/j.jpsychires.2021.09.054. View

Taribagil P, Creer D, Tahir H . 'Long COVID' syndrome. BMJ Case Rep. 2021; 14(4). PMC: 8057566. DOI: 10.1136/bcr-2020-241485. View

Boutou A, Asimakos A, Kortianou E, Vogiatzis I, Tzouvelekis A . Long COVID-19 Pulmonary Sequelae and Management Considerations. J Pers Med. 2021; 11(9). PMC: 8469288. DOI: 10.3390/jpm11090838. View

Najafloo R, Majidi J, Asghari A, Aleemardani M, Kamrava S, Simorgh S . Mechanism of Anosmia Caused by Symptoms of COVID-19 and Emerging Treatments. ACS Chem Neurosci. 2021; 12(20):3795-3805. DOI: 10.1021/acschemneuro.1c00477. View

Wu L, Wu Y, Xiong H, Mei B, You T . Persistence of Symptoms After Discharge of Patients Hospitalized Due to COVID-19. Front Med (Lausanne). 2021; 8:761314. PMC: 8645792. DOI: 10.3389/fmed.2021.761314. View

Bliddal S, Banasik K, Pedersen O, Nissen J, Cantwell L, Schwinn M . Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients. Sci Rep. 2021; 11(1):13153. PMC: 8222239. DOI: 10.1038/s41598-021-92045-x. View

Hayes L, Ingram J, Sculthorpe N . More Than 100 Persistent Symptoms of SARS-CoV-2 (Long COVID): A Scoping Review. Front Med (Lausanne). 2021; 8:750378. PMC: 8591053. DOI: 10.3389/fmed.2021.750378. View

10.

Jennings G, Monaghan A, Xue F, Mockler D, Romero-Ortuno R . A Systematic Review of Persistent Symptoms and Residual Abnormal Functioning following Acute COVID-19: Ongoing Symptomatic Phase vs. Post-COVID-19 Syndrome. J Clin Med. 2021; 10(24). PMC: 8708187. DOI: 10.3390/jcm10245913. View

11.

Dzubera A, Chochol J, Illes R, Chocholova A, Zemkova E . Vertebral Algic Syndrome Treatment in Long COVID-Cases Reports. Int J Environ Res Public Health. 2021; 18(21). PMC: 8582844. DOI: 10.3390/ijerph182111457. View

12.

Mohammed Mohiuddin Chowdhury A, Karim M, Ali M, Islam J, Li Y, He S . Clinical Characteristics and the Long-Term Post-recovery Manifestations of the COVID-19 Patients-A Prospective Multicenter Cross-Sectional Study. Front Med (Lausanne). 2021; 8:663670. PMC: 8416537. DOI: 10.3389/fmed.2021.663670. View

13.

Marshall H, Stewart N, Chan H, Rao M, Norquay G, Wild J . In vivo methods and applications of xenon-129 magnetic resonance. Prog Nucl Magn Reson Spectrosc. 2021; 122:42-62. PMC: 7933823. DOI: 10.1016/j.pnmrs.2020.11.002. View

14.

Greenhalgh T, Knight M, ACourt C, Buxton M, Husain L . Management of post-acute covid-19 in primary care. BMJ. 2020; 370:m3026. DOI: 10.1136/bmj.m3026. View

15.

Estiri H, Strasser Z, Brat G, Semenov Y, Patel C, Murphy S . Evolving phenotypes of non-hospitalized patients that indicate long COVID. BMC Med. 2021; 19(1):249. PMC: 8474909. DOI: 10.1186/s12916-021-02115-0. View

16.

Mahase E . Covid-19: What do we know about "long covid"?. BMJ. 2020; 370:m2815. DOI: 10.1136/bmj.m2815. View

17.

Vollbracht C, Kraft K . Feasibility of Vitamin C in the Treatment of Post Viral Fatigue with Focus on Long COVID, Based on a Systematic Review of IV Vitamin C on Fatigue. Nutrients. 2021; 13(4). PMC: 8066596. DOI: 10.3390/nu13041154. View

18.

Sudre C, Murray B, Varsavsky T, Graham M, Penfold R, Bowyer R . Attributes and predictors of long COVID. Nat Med. 2021; 27(4):626-631. PMC: 7611399. DOI: 10.1038/s41591-021-01292-y. View

19.

Callard F, Perego E . How and why patients made Long Covid. Soc Sci Med. 2020; 268:113426. PMC: 7539940. DOI: 10.1016/j.socscimed.2020.113426. View

20.

Pilloni G, Bikson M, Badran B, George M, Kautz S, Okano A . Update on the Use of Transcranial Electrical Brain Stimulation to Manage Acute and Chronic COVID-19 Symptoms. Front Hum Neurosci. 2020; 14:595567. PMC: 7689057. DOI: 10.3389/fnhum.2020.595567. View